Instead of writing out prescriptions on a piece of paper, doctors will perform this function directly into their electronic medical record. The prescription travels from their computer to the pharmacy’s computer. Electronic prescriptions are sent electronically through a private, secure, and closed network – the Surescripts network.
Surescripts' e-prescribing services allow physicians to electronically send prescriptions from their offices to more than 54,000 retail pharmacies and six of the largest mail order pharmacies. In addition, Surescripts provides physicians with electronic access to their patients' prescription benefit and medication history.
Lexi-Data is the foundation of Lexicomp's clinical decision support architecture is quickly becoming the standard for when companies need an up-to-date comprehensive drug database. This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, supports Surescripts Certification, Drug Classifications, dose range checking (adult and pediatric), Patient Education, and more.
As more and more healthcare professionals are adopting EMR technology to meet Meaningful Use requirements, we are receiving more and more interest from dentists about adding clincial decision support technology into their dental practice management system. They are quickly realizing that Lexicomp is the preferred vendor of choice to work with, because we provide the very best dental specific drug database to integrate into their EMRs as well as personalized customer support during development. Another important piece to consider in a dental EMR is an ePrescribing tool. Lexicomp has a close partnership with DoseSpot to deliver this solution. By selecting DoseSpot for ePrescribing, our clients are able to get to the market faster and reduce their headaches in developing the tool on their own.
Lexi-Data provides the drug information for dose range checking, pediatric dosing, drug calculators, medicine interactions, dosage precautions, clinical guidelines, drug interaction software, duplicate therapy, drug classifications, generic drug names, drug nomenclature and more. These are critical paths for a dental EMR build.
To learn more about Lexicomp's dental solutions, please visit our website at http://www.lexi.com/individuals/dentistry/
If you are interested in learning more about our integration capabilities, we'd love to talk with you. Please contact us at 1-877-819-6883.
More EMRs are calling Lexi-Data their preferred choice every month, why might you ask?
Better quality information with faster updates and fewer mistakes
A more clinically relevant focus that their end users valued
Easier implementation and more powerful functionality
Superior customer service
Unique content not available elsewhere, like Lexicomp’s industry-leading Pediatric Dose Range Checking
Come see for youself! Lexicomp will be exhibiting at HIMSS 2012 in Las Vegas from February 20 - 24. Stop by for a visit at Booth #5134 and learn more about the preferred choice of drug information databases!
Lexicomp will be attending HIMSS 2012 in Las Vegas. This will be a great opportunity for any EMR, Hospital, or Consumer Health Site to visit booth #5134 and learn about our solutions for implementing decision support for drug interactions, duplicate therapy, drug allergies, and dose range checking, as well as drug databases, and patient education information for consumers.
At HIMSS 2012 there will be live demonstrations showing how our drug databases can be implemented and customized to meet the various specific needs of EMR vendors. Stop by and see us if you are a current customer or are looking to implement drug information or clinical decision support into your application.
Are you developing EMRs and practice management systemswhere speed to market is critical?One of the modules of such systems is the inclusion of drug information.Since this is neither the expertise of your developers nor your content people,it is important to identify the preferred drug information provider early in the process.Fourcriteria are critical in making this decision.First,quality of information.Second,flexibility of design and APIs.Third,simplicity of data structure.Fourth,and very important,customer support during the development period and after release. More and more EMRs are now using Lexicompdrug information as part of their offering.And there is a reason for that.
Lexi-Data is the foundation of Lexicomp's clinical decision support architecture is quickly becoming the standard for when companies need an up-to-date comprehensive drug database. This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, supports Surescripts Certification, Drug Classifications, dose range checking (adult and pediatric), Patient Education, Pediatric and neonatal drug interactions and more.
ePrescribing is offered as a way to prevent medication errors that arise due to difficulties in reading or understanding handwritten prescriptions. ePrescribing could also reduce adverse drug events (ADEs) by making information such as drug interactions and contraindications available to prescribers at the time they are preparing a prescription.
Lexi-Data is the foundation of Lexicomp's clinical decision support architecture is quickly becoming the standard for when companies need an up-to-date comprehensive drug database. This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, supports Surescripts Certification, Drug Classifications, dose range checking (adult and pediatric), Patient Education, and more.
Lexicomp has now released the second phase of a comprehensive web services solution to EMR developers to access drug information. For those EMR and Practice Management systems that do not want to store drug information in their product, they now have an option. In the second phase, Lexicomp has released web services to include a proprietary Black Box warning decision tool to reduce alert overload. Phase II also include dose range checking (DRC) and 12 new searching tools.
For EMR developers that have need for any of the following drug nformation or tools in their product, Pediatric Dose Range Checking (Lexicomp is the leader in this area); Patient Education Materials; Drug Interaction Software; RxNorm Mapping; Medicine Lists, Generic Drugs; Dose Information; ePrescribing, and more--- they should call Lexicomp.
As Matt Bennardo pointed out, when EMR and EHR companies are under development and they are looking to include drug and medicine information, they must given proper consideration to the quality of the drug information, the ease of installation, and the level of customer service provided by the drug data provider. In order to meet the Meaningful Use standards, the EMR and EHR developers now care more about drug and medicine information than ever before. They now care about drug interactions, drug-drug and drug-allergy interactions, adverse drug events, patient education pamphlets, dose information, pediatric dosing inforamation, drug brand names and drug generic names.
Hundreds of Lexi-Data customers are now integrating Lexicomp reference and transaction drug information into their systems under development. As Matt had said:
"Comprehensive data covers all decision support Meaningful Use requirements:
Compatible with required standards like RxNorm
Supports drug-drug and drug-allergy interaction checking
All data necessary for ePrescribing and CPOE
Additional functionality like dose range checking
Fastest and easiest integration gets you to market faster:
Easy-to-use APIs and web services -- you choose which you want
Superior one-on-one customer service
Most intuitive data structure and fastest implementation
New features set you apart from the competition:
Black Box Warning filters to alleviate clinician alert fatigue
Patient education available in 19 languages
Click the links on this page to find out more about Lexi-Data now!"
Lexicomp is the seller of Lexi-Data, a transactional drug interaction database for EHR vendors, EMR vendors, HIS systems, ePrescribers, PMS systems, consumer websites, patient portals, and more. Hundreds of Lexi-Data customers are integrating Lexicomp's referential and clinical decision support information into their own systems and products.
Comprehensive data covers all decision support Meaningful Use requirements:
Compatible with required standards like RxNorm
Supports drug-drug and drug-allergy interaction checking
All data necessary for ePrescribing and CPOE
Additional functionality like dose range checking
Fastest and easiest integration gets you to market faster:
Easy-to-use APIs and web services -- you choose which you want
Superior one-on-one customer service
Most intuitive data structure and fastest implementation
New features set you apart from the competition:
Black Box Warning filters to alleviate clinician alert fatigue
Patient education available in 19 languages
Click the links on this page to find out more about Lexi-Data now!
Medication errors and adverse drug events are serious issues in healthcare. Apprx 770,000 injuries or deaths related occur each year. For this reason and to comply with the certification and meaningful use requirements, every EMR should look at partnering with and providing their customers top rated drug interaction, duplicate therapy, allergy and dose range checking information integrated into their EMR. Lexicomp and the Lexi-Data product can offer this solution.
This information and its quality, customizability, and delivery format can really set your EMR apart from the competition. In 2010 the EMR market grew by almost 13.5% while competition in this area is also growing at a higher than predicted rate. More and more physicians are now starting to look at implementation of an EMR although the rate of adoption has been slowed by the complicated maze of meaningful use. None the less, it is critical that EMRs differentiate and help physicians understand how to navigate through this maze. Drug Data Vendors that are able to offer what others may not can help these EMR companies win more deals. Drug interactions that are cusomizable, dose range checking for specific populations (adult, pediatric, geriatric) duplicate therapy checking and an overall solid patient education offering are areas that can be easily implemeted from Lexi-Data. Lexicomp's expertise and customer service can also help get you up and running fast. The database is easy to work with, available in mutliple formats and even has a web-service set can help start up and established EMRs build the structure needed to help physicians.
Does your EHR meet the certification requirements established by ONC? Lexicomp can help by providing your system key clinical decision support data required for certification. As an integrated component of your EHR, our transactional drug data and reference information support the following Stage 1 meaningful use and certification criteria from ONC's Final Rule.
Lexi-Data is the foundation of Lexicomp's clinical decision support architecture. This product provides clinical decision alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, Drug Classifications, dose range checking (adult and pediatric) and more.
It is estimated that each year some 530,000 adverse drug events take place among Medicare beneficiaries alone because of drugs negatively interacting with other drugs the patient is already taking, or insufficient information about the patient’s medical history. The Institute of Medicine (IOM) reported last year that more than 1.5 million Americans are injured annually by drug errors in hospitals, nursing homes and doctor’s offices. These negative drug events may require costly interventions in order to stabilize the patient, including hospitalization.
Electronic prescribing (eRx) has been recognized as an important step in moving health care from a paper-based legacy to a new electronic platform. The use of ePrescribing has been incentivized by the federal government, specifically via the Centers for Medicare and Medicaid Services (CMS).
Lexi-Data is the foundation of Lexi-Comp's clinical decision support architecture. This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, Drug Classifications, dose range checking (adult and pediatric) and more.
Since the beginning of the government's Meaningful Use incentive plan, specialists have been in a strange position. Although they were eventually granted the right to seek exceptions from certain measurement criteria that didn't apply to their fields, they are still required to implement fully functional EMR or EHR systems that can do everything the CMS and ONC stipulate.
An increasing number of dentists are in the same boat as well, as state mandates require them to implement systems that include functionality (like ePrescribing) that they may only use occasionally. This means that EMR vendors who create systems for specialists and dentists are now looking for ways to implement the broader functionality required by law without raising prices on their customers who may not see much value in it.
What are web services and how can they help? Web services are a different method of accessing some of the functionality required by Meaningful Use and state mandates. Instead of implementing and updating a database in-house to drive the functionality, web services allow a vendor to access information remotely only when needed. By using web services, you don't need to expend valuable development resources on non-essential functions. You can also arrange with a vendor like Lexicomp to pay only for the functionality that you'll be using.
When it comes to functions like ePrescribing, dose range checking, interaction checking, and allergy checking, web services aren't appropriate for everyone. Heavy users of those functions will still want to have a local database they can quickly query with reliable redundant back-ups. But for those who consider this functionality a low priority or infrequent need, web services offer a new, more easily implemented, and sometimes less expensive solution to help dentists and specialists meet government requirements.
Nothing is final yet, but in all likelihood Meaningful Use Stage 2 won't kick in until 2014. In addition, some of the draft recommendations floating around look a lot like Stage 1 with stricter compliance levels. In other words: much of the work for Stage 2 is going to fall on EPs and hospitals, rather than on EMR vendors. There will likely be some new functionality -- especially around provider-patient communication -- but probably not the crush of requirements we saw in Stage 1.
So what will EMR, EHR, and HIS vendors do with their reprieve? If they're smart, they'll take this opportunity to improve their products in ways that aren't (yet!) required by Meaningful Use but which will give them an advantage in the market. Here's some functionality that EMRs may be using this reprieve to pursue:
Implementing dose range checking: From a clinical point of view, this is one of the big gaps in what we've seen so far in the first two stages of Meaningful Use. Many of the news stories we read about adverse drug events aren't about interactions or allergies at all -- they're about mistakes in dosing. This is especially true with pediatric dosing, which can be extremely complicated. If dosage precautions were more widely implemented, patient safety would be positively affected.
Addressing alert fatigue: Many EMR systems are likely to live or die based on this issue alone. Whoever can figure it out will have an undeniable benefit over the competition. As with many Meaningful Use issues, it starts with drug information vendors -- does yours provide the detail needed to make alerts intelligent?
Improving patient education: The new recommendations for Stage 2 Meaningful Use are all about provider-patient communication. And transcripts of workgroups show that CMS and ONC are very interested in improving not just the method of communication, but the quality of information that flows through it. It seems likely that this will eventually include things like specific patient education materials for pediatric and adult patients, delivered in the language they primarily speak.
EMR vendors that can solve some or all of these issues now will find themselves ahead of the game when the next round of MU guidelines come out. Not only that, but they'll be delivering real value to clinicians that sets them apart from all the other cookie-cutter competitors who are simply "checking boxes" on the Meaningful Use checklist.
But where to start? Lexicomp is a drug and clinical information vendor who can help with all of the items listed above -- and with many more as well. Call or fill out a form today to start learning about how Lexicomp can help you build value for your users, save money and development resources, and meet government requirements for your EMR system.
First, if you are developing a new EMR or application that requires inclusion of drug and medicine information, don't delay the process of securing a drug data vendor. With the new certication rules you are better off finding a vendor who is easy to work with, flexible and supportive. There are only a few drug data providers in the market, so it shouldn't be difficult to idenitfy them.
Secondly, pediatric and neonatal dose ranging checking is becoming more of a must everyday. The web-based EHR company, Practice Fusion, released a study earlier this year where it has been shown that EHR's are having a real impact on the decrease of infant mortality. This is great news in general and hats off to those EHR's that have elected to focus some of their development efforts on dose range checking.
As my colleague Matt Bennardo posted several months ago, "There are drug information vendors like Lexicomp that understand there is a vast world of difference between adults and children. Lexicomp's durg information is trusted by dozens of EMR vendors to guide clincians in prescribing, fulfilling and admnistering drugs to patients of all types --- including children."
If you are the beginning of process of developing a new EMR or looking to modify a current EMR, contact Lexicomp for some suggestions.
I am reposting comments I made several months ago. Why? Because it is very important to build an EMR with the best pediatric dosing information possible. The implication are clear. So, if you are in the midst of building a new EMR or just want to include a link from your EHR over to Lexicomp Online's Pediatric Dose Range Checking, I would suggest reading this.
It might seem like an easy question, but the answer is neither obvious nor unimportant. Both pediatric and neonatal dose range calculators are receiving more focus and attention. This is serious business, with serious consequences. Last week, Matt Bennardo wrote a blog posting wherehe cited astudy by Practice Fusion, where it has been shown that EHR's are having a real impact on the decrease in infant mortality. This is great news for those EHR's that have elected to use better dose range checking calculators.
As I said in a post last week. "Allpediatric dosage calculatorsare not created equally. As Matt goes on to say, "But luckily there are drug information vendors like Lexicomp that understand there is a vast world of difference between adults and children -- and often between older children and neonates. Lexicomp's drug information is trusted by dozens of EHR vendors to guide clinicians in prescribing, fulfilling, and administering drugs to patients of all types -- including children."
Lexicomp provides both "machine readable" transactional information (geared towards specific populations) for use in clinical decision support, as well as "human readable" reference materials for clinicians and patients. Even Lexicomp's patient education leaflets are written with either adult or pediatric patients in mind.
If you are developing an EMR or looking to improve an EHR or HIS system, I would suggest reaching out toLexicompfor some suggestions. Lexicomp is known for its pediatric and neonatal drug information.
Great drug reference databases do not grow on trees. If you are in the midst of developing or redesigning an EMR or EHR, then you already know this. There are lots of key questions to keep in mind throughout the decision process:
How much will they help in setting up the API's?
Do they have a specific pediatric dose range checking product?
Take a look at the marketplace and see who can meet all your needs--check out Lexicomp early in the searching process and you will be pleasantly surprised.
In the last two years Lexicomp has quickly become a major provider of drug information to EMR companies for clinical decision support. Many of the new EMRs hitting the market are using Lexicomp medicine information for drug interactions, dose range checking, therapeutic dosages, adverse drug advents, electonic eprescring, and more. Lexi-Data has become the popular choice based on top quality information, unparalleled customer service, state-of-the-art data structure and top-notch APIs. Now something new!!
Lexi-Data has introduced a new structure which allows for the customization of Black Boxed Warning to reduce alert fatigue, yet at the same time delivers the warning to the person who needs it most. This information structure is new and as far as we know not available elsewhere.
API and Database Features:
Incorporates not only the BBW as published within the package insert, but also pulls contextual or supporting information as written by Lexicomp clinical experts
Each summary is broken down and tagged as separate messages / instructions
Each message is paired to a recipient user category – this allow for differentiating where in the workflow of an EMR the message may be displayed
Can be filtered for a more specific and targeted set of messages to clinician/recipient groups, as defined for their site
This is terrific stuff. So for anyone developing drug interaction software or eprescribing modules, this is something you will want to look into.
EMR vendors are not the only ones rapidly deploying clinical decision support systems to healthcare providers. Dental professionals are demanding that their practice management systems overcome massive development hurdles in order to comply with Meaningful Use standards.
There is a buzz in the dental technology community about Meaningful Use and incorporating more clinical decision support into the practice management system workflow. If you are searching for the best dental specific drug database to integrate into your dental EMR, turn to Lexicomp. There are very few suppliers of drug data within the dental market and even fewer still that are easy to work with. And if you are looking for an easy-to-use, out-of-the-box ePrescribing tool, trust our partner DoseSpot to deliver the solution. What do all of these companies have in common? They are easy to work with and provide you with the ability to get to the market fast!
Don't wait to the end of your development process to worry about: dose range checking, pediatric dosing, drug calculators, medicine interactions, dosage precautions, clinical guidelines, drug interaction software, duplicate therapy, drug classifications, generic drug names, drug nomenclature and more. These are critical paths for a dental EMR build. But it's not just about the information. It's about who you select as your partner and who has seamless API's which makes your development easier.
You owe it to your product and your customer to make the right choice.
What do these words have in common? "Pediatric dosing information;Medicine lists; Medicine brand names; Drug-drug interaction; Drug-allergy interactions; Drug interaction database; ePrescribing; Patient education."
There are many EMR products under development, many targeting smaller hospitals and ambulatory facilities. There are also a number of other EMR and Practice Management products that are going through major product re-design. Many of these development groups need to confront the decision about what drug information supplier to use. As the title of this posting says "EMR developers are now searching for drug and disease information providers that are easy to work with" (Note: most are not). This might not sound like a tall order, but as it turns out, it is much more difficult than they think. It's about the data as much as it about the quality of the relationship as well as the flexibility and helpfulness of the vendor.
How much will they help in setting up the API's? Do they have a specific pediatric dose range checking product? Do they have patient education leaflets? Are they available in foreign languages?
Powered by Compendium